Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Inclusion Criteria

• •Type 1 or type 2 diabetic patients
• •Performing auto-glycaemic control (at least 2 glycemias a day)
• •Treated with insulin by a basal-bolus regimen for at least 1 year and using the same method of administration for at least 3 months (insulin pen or pump)
• •Who have an Apple® or Androïde® Smartphone compatible, or intend to acquire one before their participation in the study
• •Whose HbA1c dating of less 1 month and more than 3 months is ≥ 8%
• •Who are able to understand and follow the study protocol
• •Who have given their signed consent to take part in the study
• •Subject affiliated to the French National Health Insurance funds or benefiting from such insurance